We are witnessing the first step toward meaningful longevity. True healthspan starts by taking control, through proactive and data-driven diagnosis. That’s exactly what Aeon’s exceptional team is building: the most advanced AI-driven preventive healthcare platform, seamlessly combining whole-body MRI screening, blood biomarkers, and genetic data into one integrated model. Fully aligned with the startup’s mission, at GoHub Ventures we’re proud to announce our participation in their €8.2M Seed round.
A Mission-Driven Founder
From our very first interaction, Aeon’s co-founder and CEO Tim Seithe impressed us with an uncommon clarity of vision and deep conviction. A trained physician and repeat founder with two successful exits, Tim brings together scientific discipline and entrepreneurial ambition.
But what truly stood out was his unwavering commitment to Aeon’s mission: to fundamentally reshape how we approach health. Despite already achieving financial independence, he is fully dedicated to building a global category leader in preventive care. He leads with intensity and full transparency, driving a high-performance culture from Aeon’s Zurich headquarters.
The Problem: Traditional Healthcare is Collapsing
Healthcare systems, burdened by rising costs, aging populations, and outdated infrastructures, are structurally misaligned with long-term preventive strategies. For payers, prevention remains economically unproven in traditional reimbursement models, favoring acute care’s immediate Return on Investment over decades-long health dividends.
Investment in AI-driven diagnostics and preventive medicine has surged globally in Q1 2025, as people are no longer willing to just live longer, but to live better. While Europe still trails the U.S., markets like Switzerland and the UK are beginning to lead the transition. With over 80% of public healthcare budgets still focused on treating chronic conditions, the rise of out-of-pocket preventive care is inevitable, and it’s only a matter of time before insurance coverage follows.
“Science-backed longevity and evidence-based health optimization content are showing a new way to rethink healthcare. People have already changed their mindset. Now it’s time for institutions to catch up.” noted Inés Calabuig, Managing Partner at GoHub Ventures.
The Solution: Aeon’s AI-Driven Medical Check-Up
Aeon is tackling one of the most pressing challenges in healthcare: how to detect and prevent chronic disease before symptoms appear. Their solution offers a comprehensive, non-invasive screening that merges MRI (with no radiation or contrast), blood biomarker panels, and genetic analysis: all unified by a proprietary AI engine.
Two core innovations set Aeon apart:
- First, their asset-lite model: instead of building their own clinics, Aeon partners with top-tier imaging centers and labs across Europe. This allows them to scale faster and more efficiently, while focusing on their core IP; data integration, prediction algorithms, and patient UX.
- Second, their multimodal approach enables cross-validation between phenotypic (MRI), metabolic, and genomic data, significantly increasing diagnostic precision and reducing false positives. In a market plagued by overdiagnosis and low-value screenings, this is a game-changer.
What’s Next for Aeon?
In just a few months, Aeon has launched its service in Switzerland, signed strategic partnerships with leading MRI providers across Europe, and secured insurance reimbursement coverage of up to 80% with two major Swiss insurers: a global first for a preventive health startup. With outstanding revenue and growth metrics from a single clinic and conversion rates above 70%, the early traction is a strong signal of both demand and operational excellence.
Aeon’s ambition doesn’t stop at diagnostics. Their long-term vision is to move from detection to prediction: building a digital twin of the human body that helps patients, doctors, and insurers make informed decisions based on individual risk. As they expand to new markets like the UK and launch targeted scan protocols (for athletes, metabolic risk, brain health, and more), Aeon is laying the foundation for a platform that can personalize care at scale.
We believe the shift toward proactive healthcare is inevitable. The winners will be those who combine medical depth, scalable technology, and business model clarity. Aeon checks all three boxes. We’re proud to partner with Tim and the team as they pioneer this next frontier in longevity and prevention.
